Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Anna Takada"'
Autor:
Tadahiro Shoji, Toru Sugiyama, Masahiro Kagabu, Hideo Omi, Takayuki Nagasawa, Satoshi Takeuchi, Tatsuya Honda, Eriko Takatori, Fumiharu Miura, Anna Takada
Publikováno v:
OncoTargets and therapy
Eriko Takatori, Tadahiro Shoji, Anna Takada, Takayuki Nagasawa, Hideo Omi, Masahiro Kagabu, Tatsuya Honda, Fumiharu Miura, Satoshi Takeuchi, Toru Sugiyama Department of Obstetrics and Gynecology, Iwate Medical University School of Medicine, Iwate, Ja
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::88948cc2ff953bf07ac3f8090d8d1538
https://doi.org/10.2147/ott.s101146
https://doi.org/10.2147/ott.s101146
Publikováno v:
OncoTargets and therapy
A case study using mammalian target of rapamycin complex 1 in recurrent ovarian clear cell carcinoma (CCC) was recently conducted. We report our experience with a patient suffering from recurrent ovarian CCC who achieved long-term disease control wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::49facb54225ccbc31746bada315735fc
http://europepmc.org/articles/PMC3913549
http://europepmc.org/articles/PMC3913549
Autor:
Masahiro Kagabu, Toru Sugiyama, Yuki Miura, Eriko Takatori, Anna Takada, Tadahiro Shoji, Hanae Niinuma, Yasuko Suga, Yoshitaka Kaido, Satoshi Takeuchi
Publikováno v:
International Journal of Clinical Oncology. 19:336-340
The efficacy and safety of S-1/oxaliplatin (SOX) therapy in patients with recurrent adenocarcinoma of the uterine cervix were examined in a pilot study. S-1 was orally administered for 14 days at a dose of 80–120 mg/body/day to 7 patients with recu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b257e257b1c9b354634a01413ef10435
https://doi.org/10.1007/s10147-013-0539-4
https://doi.org/10.1007/s10147-013-0539-4
Autor:
Masahiro Kagabu, Toru Sugiyama, Tadahiro Shoji, Yuki Miura, Takayuki Nagasawa, Eriko Takatori, Miyuki Nagao, Anna Takada, Tatsuya Honda, Hideo Omi
There are currently no studies demonstrating the effects of palonosetron on delayed chemotherapy-induced nausea and vomiting (CINV) in gynecological cancer patients receiving chemotherapy with moderately emetogenic chemotherapeutic agents. We conduct
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::341b30d8a5997b87a94d67b85a0cbfc1
https://europepmc.org/articles/PMC4360756/
https://europepmc.org/articles/PMC4360756/
Autor:
Eriko Takatori, Fumiharu Miura, Toru Sugiyama, Satoshi Takeuchi, Hideo Omi, Tatsuya Honda, Masahiro Kagabu, Anna Takada, Yuki Miura, Tadahiro Shoji
Publikováno v:
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. 24(6)
ObjectivePatients with end-stage cancer have poorly controlled ascites retention resulting due to cancerous peritonitis. We intraperitoneally administered triamcinolone acetonide (TA) to patients with end-stage gynecological cancer as a pilot study,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f2ae64267e4fda27ff10a9e34e48b0bf
https://pubmed.ncbi.nlm.nih.gov/24978712
https://pubmed.ncbi.nlm.nih.gov/24978712
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 39(10)
Recently, the resistant-to-paclitaxel/carboplatin therapy(TC), the standard first-line chemo-regimen for epithelial ovarian cancer(EOC), has been reported in subtypes of EOC, such as clear cell carcinoma and mucinous adenocarcinoma. The response to t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::49a09f5df7f2931896fc7a374e6d3705
https://pubmed.ncbi.nlm.nih.gov/23064058
https://pubmed.ncbi.nlm.nih.gov/23064058
Autor:
Daisuke Aoki, Anna Takada, Tsutomu Arai, Toru Sugiyama, Akira Yoshizaki, Hiroi Kaku, Seisuke Kumagai, Shinpei Tsunoda, Tadahiro Shoji, Eiichiro Tominaga, Junzo Kigawa, Fumiharu Miura, Shinya Sato, Hiroki Onoue
Publikováno v:
Experimental and therapeutic medicine. 3(1)
Paclitaxel/carboplatin chemotherapy for cancer (TC therapy) exhibits neurotoxicity and causes peripheral neuropathy at a high frequency, which is difficult to cope with. In this study, we investigated the efficacy of Goshajinkigan, a traditional Japa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a552fed02efd79f167ab2cc731db5a2
https://pubmed.ncbi.nlm.nih.gov/22969845
https://pubmed.ncbi.nlm.nih.gov/22969845
Autor:
Takayuki Nagasawa, Ayako Iwane, Toru Sugiyama, Tomonobu Kanasugi, Naoko Izutsu, Anna Takada, Toshihiko Izutsu
Publikováno v:
Acta obstetricia et gynecologica Scandinavica. 85(1)
Human telomerase reverse transcriptase has been found in telomerase-positive tumor tissues, but not in telomerase-negative nonmalignant somatic cells.Thirty-two first-trimester chorionic villi specimens (Group A), 33 second- and third-trimester place
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::709e7d9c111220f76cee5d4859fcb25a
https://pubmed.ncbi.nlm.nih.gov/16521673
https://pubmed.ncbi.nlm.nih.gov/16521673
Autor:
Eriko Takatori, Tadahiro Shoji, Anna Takada, Takayuki Nagasawa, Hideo Omi, Masahiro Kagabu, Tatsuya Honda, Fumiharu Miura, Satoshi Takeuchi, Toru Sugiyama
Publikováno v:
OncoTargets & Therapy; Sep2016, Vol. 9, p5651-5657, 7p
Autor:
Hideo Omi, Satoshi Takeuchi, Toru Sugiyama, Tatsuya Honda, Masahiro Kagabu, Fumiharu Miura, Anna Takada, Tadahiro Shoji
Publikováno v:
Web of Science
TPS3116 Background: Despite improvement in chemotherapy including the molecular targeting agents, advanced or recurrent ovarian cancer (A/ROC) are still incurable. Some tumor associated proteins, hypoxia-inducible protein 2 (HIG2), and tumor related
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::94c3f325915492620263a978651529f5
https://doi.org/10.1200/jco.2013.31.15_suppl.tps3116
https://doi.org/10.1200/jco.2013.31.15_suppl.tps3116